Original Research
Published on 22 May 2019
Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker Profiles
in Dermatology
Frontiers in Medicine
doi 10.3389/fmed.2019.00113
- 9,904 views
- 22 citations
16 articles related to "Exhaustion Marker"
Articles
Brief Research Report
Published on 29 Apr 2024
PD-1 knockout on cytotoxic primary murine CD8+ T cells improves their motility in retrovirus infected mice
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1338218
- 4,238 views
- 4 citations
Original Research
Published on 23 Mar 2023
Immune activation and exhaustion marker expression on T-cell subsets in ART-treated adolescents and young adults with perinatal HIV-1 infection as correlates of viral persistence
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1007626
- 6,799 views
- 16 citations
Original Research
Published on 12 Aug 2020
Rhesus Cytomegalovirus-Specific CD8+ Cytotoxic T Lymphocytes Do Not Become Functionally Exhausted in Chronic SIVmac239 Infection
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2020.01960
- 4,783 views
- 3 citations
Original Research
Published on 19 Jun 2018
Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2018.01394
- 5,994 views
- 42 citations
Original Research
Published on 25 Mar 2022
Persistent Overactive Cytotoxic Immune Response in a Spanish Cohort of Individuals With Long-COVID: Identification of Diagnostic Biomarkers
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.848886
- 27,262 views
- 92 citations
Original Research
Published on 27 Jun 2022
High-Dimensional Immune Profiling by Mass Cytometry Revealed the Circulating Immune Cell Landscape in Patients With Intracranial Aneurysm
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2022.922000
- 5,158 views
- 24 citations
Original Research
Published on 16 Aug 2022
COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.954985
- 7,214 views
- 32 citations
Original Research
Published on 01 Apr 2025
Heterogeneity of γδ T-cell subsets and their clinical correlation in patients with AML
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1552235
- 3,826 views
- 1 citation
Original Research
Published on 01 Jul 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1412211
- 5,259 views
- 3 citations
Original Research
Published on 09 Feb 2022
Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.836549
- 15,500 views
- 27 citations
Original Research
Published on 13 Oct 2021
Engineered Removal of PD-1 From the Surface of CD19 CAR-T Cells Results in Increased Activation and Diminished Survival
in Cellular Biochemistry
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2021.745286
- 14,614 views
- 41 citations
Original Research
Published on 09 Apr 2024
A quality-by-design approach to improve process understanding and optimise the production and quality of CAR-T cells in automated stirred-tank bioreactors
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2024.1335932
- 8,739 views
- 13 citations
Original Research
Published on 27 Jan 2022
PiggyBac Transposon-Mediated CD19 Chimeric Antigen Receptor-T Cells Derived From CD45RA-Positive Peripheral Blood Mononuclear Cells Possess Potent and Sustained Antileukemic Function
in T Cell Biology
Frontiers in Immunology
doi 10.3389/fimmu.2022.770132
- 13,752 views
- 19 citations
Original Research
Published on 15 Nov 2024
The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1473139
- 3,323 views
- 8 citations
Original Research
Published on 10 Jan 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2017.01956
- 16,237 views
- 94 citations